Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
PTPI - Petros Pharmaceuticals Inc - Stock Price Chart
TickerPTPI [NASD]
CompanyPetros Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap3.23MEPS (ttm)-6.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.46EPS next 5Y-
P/B0.45EPS Q/Q65.49%
Dividend-Sales Q/Q214.88%
Insider Own40.25%Inst Own5.68%
Insider Trans0.00%Inst Trans2.20%
Short Float1.93%Earnings-
Analyst Recom-Target Price-
Avg Volume50.93K52W Range0.92 - 9.54
FLQM - Franklin U.S. Mid Cap Multifactor Index ETF - Stock Price Chart
TickerFLQM [AMEX]
CompanyFranklin U.S. Mid Cap Multifactor Index ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend1.22%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume54.03K52W Range40.68 - 46.72
LASE - Laser Photonics Corp - Stock Price Chart
TickerLASE [NASD]
CompanyLaser Photonics Corp
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap8.58MEPS (ttm)-0.55
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.86EPS next 5Y-
P/B0.54EPS Q/Q-416.95%
Dividend-Sales Q/Q1.23%
Insider Own59.11%Inst Own2.20%
Insider Trans0.00%Inst Trans-
Short Float0.66%EarningsNov 14/b
Analyst Recom1.00Target Price10.00
Avg Volume60.00K52W Range0.67 - 7.23
NUGO - Nuveen Growth Opportunities ETF - Stock Price Chart
TickerNUGO [NYSE]
CompanyNuveen Growth Opportunities ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend0.18%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume77.92K52W Range17.09 - 24.78
May-12-22 04:00AM Nontransparent Active ETFs Slow To Gain Traction (ETF.com)
Jan-05-22 01:00PM Another Wild Year For ETFs (ETF.com)
Nov-12-21 10:00AM Why 'NUGO' Has Gained $200M Every Day (ETF.com)
GFOF - Grayscale Future of Finance ETF - Stock Price Chart
TickerGFOF [NYSE]
CompanyGrayscale Future of Finance ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend0.55%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.89K52W Range7.14 - 18.13
LMNR - Limoneira Co - Stock Price Chart
TickerLMNR [NASD, RUT]
CompanyLimoneira Co
CountryUSA
IndustryFarm Products
Market Cap329.03MEPS (ttm)0.50
P/E36.51EPS this Y-196.87%
Forward P/E81.94EPS next Y147.02%
PEG2.43EPS past 5Y-
P/S1.85EPS next 5Y15.00%
P/B1.79EPS Q/Q-119.07%
Dividend1.64%Sales Q/Q-10.91%
Insider Own9.22%Inst Own56.67%
Insider Trans-0.09%Inst Trans-6.55%
Short Float3.24%EarningsSep 07/a
Analyst Recom1.00Target Price20.20
Avg Volume60.71K52W Range12.01 - 17.90
ZECP - Zacks Earnings Consistent Portfolio ETF - Stock Price Chart
TickerZECP [AMEX]
CompanyZacks Earnings Consistent Portfolio ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend0.83%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume14.43K52W Range22.34 - 25.72
OVB - Overlay Shares Core Bond ETF - Stock Price Chart
TickerOVB [NYSE]
CompanyOverlay Shares Core Bond ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend5.17%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume13.93K52W Range18.69 - 22.39
IWMY - Defiance R2000 Enhanced Options Income ETF - Stock Price Chart
TickerIWMY [NYSE]
CompanyDefiance R2000 Enhanced Options Income ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend6.28%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume59.05K52W Range20.08 - 23.09
CNTA - Centessa Pharmaceuticals plc ADR - Stock Price Chart
TickerCNTA [NASD]
CompanyCentessa Pharmaceuticals plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap653.72MEPS (ttm)-1.66
P/E-EPS this Y29.58%
Forward P/E-EPS next Y-8.61%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.52EPS Q/Q29.79%
Dividend-Sales Q/Q-
Insider Own40.37%Inst Own34.08%
Insider Trans-0.10%Inst Trans0.06%
Short Float2.63%EarningsNov 13/a
Analyst Recom1.40Target Price11.00
Avg Volume119.74K52W Range3.00 - 8.65
Nov-27-23 04:15PM Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals (GlobeNewswire)
Nov-16-23 09:55AM Wall Street Analysts Predict a 35.92% Upside in Centessa Pharmaceuticals PLC Sponsored ADR (CNTA): Here's What You Should Know (Zacks)
Nov-14-23 07:28PM Centessa Pharmaceuticals PLC Reports Q3 2023 Financial Results and Business Progress (GuruFocus.com) +6.25%
Nov-13-23 04:05PM Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023 (GlobeNewswire)
Nov-02-23 09:09AM Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Oct-31-23 08:00AM Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors (GlobeNewswire)
Oct-30-23 08:00AM Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.32%
Oct-25-23 08:00AM Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders (GlobeNewswire) -6.02%
Oct-03-23 08:00AM Centessa Pharmaceuticals Announces Additions to Senior Leadership Team (GlobeNewswire)
Sep-04-23 10:51AM Centessa (CNTA) Surges 72% in the Past 3 Months: Here's Why (Zacks)
134567891011121320